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Abstract
Background: Tuberculosis kills five lakh patients in India every 
year, out of which 7-12 % are with meningeal involvement. Delay in 
its diagnosis and in initiation of treatment results in poor prognosis 
and sequlae in up to 25% of cases. The aim of the present study is 
to look for a simple, rapid, cost effective, non-invasive and fairly 
specific test in differentiating tubercular etiology from other causes.     
Methods: Forty patients between the age of 6 - 24 months attending 
hospital with symptoms and signs of meningitis were selected and 
divided into two groups: tubercular and non-tubercular, depending 
upon the accepted criteria. CSF was drawn and ADA estimated. 
Results: Out of 19 tubercular patients, 18 had CSF ADA at or above 
the cutoff value while one had below. Out of 21 non-tuberculous 
patients, two had ADA levels at or above the cutoff value while 19 
had below this value. Results of our study indicate that ADA level 
estimation in CSF is not only of considerable value in the diagnosis 
of TBM, CSF ADA level 10 U/L as a cutoff value exhibited 94.73% 
sensitivity  and  90.47%  specificity  in  differentiating  tuberculous 
from  non-tuberculous  meningitis;  it  also  has  90.00%  positive 
predictive value and 95.00% negative predictive value. 
Conclusions: It can be concluded that ADA estimation in CSF 
is not only simple, inexpensive and rapid but also fairly specific 
method for making a diagnosis of tuberculous etiology in TBM, es-
pecially when there is a dilemma of differentiating the tuberculous 
etiology from non-tuberculous ones. For this reason ADA estima-
tion in TBM may find a place as a routine investigation.
Keywords: Cerebrospinal fluid; Adenosine deaminase; Tuberculous 
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Introduction
Tuberculous  meningitis  (TBM)  is  an  endemic  disease  in 
developing countries [1], more so in low socio-economic 
status.  Five  lakh  patients  of  tuberculosis  die  every  year 
in  India  [2],  8.3  %  of  which  is  childhood  tuberculosis. 
Multidrug resistance in tuberculosis and acquired immuno-
deficiency syndrome (AIDS) further worsen the outcome of 
this disease [3]. Incidence of TBM in developing countries 
is 7-12%.  Delay in diagnosis and so in the start of effective 
treatment results in poor prognosis and sequalae in up to 
25% of cases [4]. Available methods of diagnosis of TBM 
were evaluated [5] and all of them were found to have low 
sensitivity and specificity.  
The newer methods for diagnosing tubercular disease is 
based on pheno- and genotypic methods. For the detection 
of acid fast bacilli (AFB) in a smear, light microscopy is a 
common, rapid and specific method and is used the world 
over  with  a  detection  rate  of  30-40%  [6].  Sensitivity  of 
culture  on  Lowenstein-Jensen  (L-J)  medium  is  higher 
than microscopy but it needs several weeks of incubation. 
A  number  of  genotypic  assays  based  on  nucleic  acid 
amplification  have  been  designed  including  GenProbe 
amplified  Mycobacterium  tuberculosis  direct  test,  Roche 
Amplicor MTB test, Cobas Amplicor test, Abbott LCx test, 
and the BD-Probe Tec (strand displacement amplification) 
test  [7-11].  However,  high  cost  involved  in  these  tests 
prevents them to be widely used especially in developing 
countries. 
Adenosine deaminase (ADA) is an enzyme in the purine 
salvage pathway that catalyzes the conversion of adenosine 
and deoxyadenosine to inosine and deoxyinosine respective-
ly with the release of ammonia. It plays important role in 
differentiating lymphoid cells and is present in abundance in 
active T-lymphocytes whose concentration is inversely pro-
portional to the degree of differentiation [12]. Its levels are 
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ten times higher in T-lymphocytes than in erythrocytes. The 
enzyme activity increases during mitogenic and antigenic re-
sponses of lymphocytes and T-lymphocyte blastogenesis can 
be inhibited by inhibitors of ADA. Likewise, a deficiency of 
adenosine deaminase is associated with severe defects in the 
cell mediated and the humoral arms of the immune system, 
predisposing the patient to opportunistic infections. 
ADA is released by T cells during cell mediated immune 
response (CMI) to the tubercle bacilli. ADA is now being 
recognized as a marker of cell mediated immunity particularly 
as  a  marker  of  T  lymphocyte  activation.  Adenosine 
deaminase  levels  (ADA)  have  also  been  considered  by 
several researchers to differentiate tubercular disease from 
non-tubercular [13-17].  
Different modalities to support the diagnosis in cases 
of TBM have to be considered because the cytological and 
biochemical analysis of cerebro-spinal fluid (CSF) have a 
considerable overlap. As few studies have been conducted 
to evaluate the role of CSF ADA levels for the diagnosis of 
TBM, we tried to estimate ADA levels in CSF in TBM and to 
find out its role as a sensitive, accurate, rapid, and affordable 
diagnostic tool that will work in resource-limited settings in 
confirming the tubercular etiology in cases of meningitis.
 
Patients and Methods 
Routine  procedures  of  history  taking,  examination  and 
routine investigations were followed. Forty patients between 
the age of six months to two years having symptoms and 
signs of meningitis, admitted in the Pediatrics ward from 
July 2009 to June 2010 at the Subharti Medical College, 
Meerut, India were included in the present study. 
Presence  of  first  or  more  than  one  of  the  following 
criteria was adopted to label a case as tuberculous: 
1. Bacteriological proof of presence of Mycobacterium 
tuberculosis.
2. Biopsy showing caseating granulomas.
3. Clinico- radiological findings consistent with TB.
4. Definite clinical and radiological improvement in one         
    month after specific anti-tubercular treatment.
5. History of contact with current disease and positive 
reaction  (>  20  mm  induration)  to  5  tuberculin  unit  (TU) 
purified protein derivative (PPD). 
Lumbar puncture was done in each case and at least 2 
ml of CSF was collected in a sterile vial. Hemorrhagic CSF 
was excluded from the study. This CSF was subjected to 
biochemical  and  microscopic  examination.  ADA  activity 
  Table 1. Distribution of the Cases According to Sex Table 2. Distribution of the Cases According to Accepted 
Criteria
Sex Number of cases
Male 28
Female 12
Total 40
Group Number of cases
Tuberculous 19 (47.5%)
Non-tuberculous 21 (52.5%)
Total 40
Table 3. Distribution of the Cases According to Set Criteria and CSF ADA Levels
Group Number 
of cases
ADA levels 
in U/L
Mean SD t cal P-value
Tuberculous 19 ADA ≥ 10 
ADA < 10
18
01
  27.1684 
  22.7660
4.0173 0.0007
(p<.01)*
Non-tuberculous 21 ADA ≥ 10
ADA < 10
02
19
6.0619  
2.5714
Total 40 40
 
*(p < 0.01) shows a highly significant difference between the tuberculous and non-tuberculous groups
220                                                                                                                                                 221J Clin Med Res  •  2010;2(5):220-224           CSF ADA in TBM Patients
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
was estimated in all these patients by the method of Guisti 
[18] and was expressed as U/L. Cutoff reference range of 10 
U/L CSF ADA was taken as positive.
Results
Out of 40 patients, 28 children were male and 12 patients 
were female (Table 1). Nineteen patients (47.5%) having 
fulfilled the criteria were labeled as tubercular, while the 
other 21 (52.5%) were labeled as non-tubercular (Table 2). 
Only two (10.52%) patients in 19 tubercular had evidence of 
presence of Mycobacterium.
     Out of these 19 tuberculous patients, 18 patients were 
found to be having CSF ADA at or above the cutoff value 
while only one had below cutoff value. Of the 21 patients 
labeled  non-tuberculous,  two  patients  were  found  to  be 
having CSF ADA at or above the cutoff value while 19 had 
values below the cutoff (Table 3).
In  tuberculous  group  ADA  activity  in  CSF  ranged 
between 9.2 to 110 U/L with a median of 22, mean SD as 
27.1684 (ADA ≥ 10) and 22.7660 (ADA < 10). While in 
non-tuberculous group ADA activity ranged between 2 to 
10.5 U/L with a median of 6, mean SD as 6.0619 (ADA ≥ 
10) and 2.5714 (ADA < 10).
     On comparison of the values of CSF ADA in the two 
groups, t cal is 4.0173 and the difference in these two values 
was found highly significant (p<0.01) (Table 3).
Discussion
  
Demonstration of AFB in CSF, CSF culture, CSF cytology, 
and  genomic  amplification  are  the  various  means  to 
confirm the etiology of TBM but visualization of AFB in 
direct smears or in cultures of CSF is usually difficult [19] 
and in most cases negative. Newer methods such as those 
involving bacterial genomic amplifications by PCR or other 
comparable methods, are not available for widespread use in 
the developing countries.
      Routine CSF laboratory findings may not be helpful to 
differentiate tuberculous etiology in meningitis from other 
causes. The aim is to look for a simple and rapid test that can 
help in the diagnosis of TBM and differentiate it from other 
causes with fairly good accuracy. 
       ADA has been considered as a marker of cell-mediated 
immunity  and  its  activity  has  been  observed  in  various 
infections including TBM. Considering that both humoral 
and cell-mediated immunity play an important role in TBM 
infection, it has been suggested that ADA activity in CSF 
may  help  differentiate  TBM  from  non-TBM  infectious 
meningitis.
        CSF  - ADA  estimation  was  reported  to  be  useful  in 
diagnosing  TBM  and  to  differentiate  TBM  from  normal 
subject or patients with other neurological disorders [20]. 
CSF – ADA estimation is a useful method to differentiate 
TBM from aseptic meningitis [13]. Other researchers have 
also observed the usefulness of CSF-ADA activity in the 
diagnosis of TBM [21, 22]. 
      In the present study CSF - ADA level 10 U/L as a cut-
off  value  differentiate  tuberculous  from  non-tuberculous 
meningitis.  We  have  observed  a  highly  statistically 
significant difference in the CSF - ADA levels of meningitis 
due to tuberculosis and non-tuberculous etiology (P < .01) 
(Table 3). Results of our study indicate that ADA levels in 
CSF are of considerable value in diagnosis of TBM and in 
differentiating  this  disease  from  others  because  a  cut-off 
CSF - ADA level of 10 U/L exhibited fairly high accuracy 
with  sensitivity  of  94.73%,  specificity  of  90.47%  for  the 
diagnosis  of  tuberculous  meningitis.  In  addition  to  this, 
the positive predictive value of test is 90.00% with overall 
accuracy being 95.00% (Table 4). In cases where there is a 
dilemma in confirming the etiology, CSF ADA levels help in 
reaching out to a conclusion, and depending upon the values 
of ADA, patient may be diagnosed and treated.
      Levels of ADA in CSF of adult patients of TBM have 
been evaluated in earlier studies [12-14]. Raised levels of 
ADA in CSF are not specific to meningeal inflammatory dis-
ease but it can be a test for confirming its etiology with good 
predictive value. Raised ADA levels have also been noted in 
Table 4. Distribution of the Cases According to True and False Positivity and Negativity and 
Statistical Accuracy
Cell Entries Number 
of Cases
Statistical Indices of Diagnostic 
Accuracy
Percentage
True Positive 18 Sensitivity 94.73%
False Negative 01 Specificity 90.47%
True Negative 19 Positive predictive valve 90.00 %
False Positive 02 Negative predictive value 95.00%
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other conditions particularly in certain intracranial tumors 
[15].
Gupta et al [16] observed that adenosine deaminase lev-
els in nontuberculous disease rarely exceeded the cut-off; set 
for tuberculous disease. They [17] have further observed that 
ADA estimation is not only a fairly sensitive and specific 
test (more than 90 %), helpful in differentiating tubercular 
from non-tubercular etiology; both in pulmonary and extra-
pulmonary disease but is also simple, inexpensive and rapid. 
For this reason this test may help in early diagnosis, improve 
the prognosis and reduce spread of disease and sequlae. 
        The mean ADA levels in CSF of TBM cases of pedi-
atric age groups have been reported to be ranging between 
11.6-13.7 U/L in earlier study [12]. A level 15.7 - 21.3 U/L 
has been observed in adult TBM patients [13, 14]. These re-
sults show that levels of ADA vary in different age groups. 
In our study CSF ADA levels were found to be 9.2 to 110 
U/L in tuberculous group with a median of 22, mean SD as 
27.1684 (ADA ≥ 10) and 22.7660 (ADA < 10); while in non-
tuberculous group ADA activity ranged between 2 to 10.5 
U/L with a median of 6, mean SD as 6.0619 (ADA ≥ 10) and 
2.5714 (ADA < 10). All the patients were between the age 
group of 6 to 24 months. This may be due to difference in 
immunological reactivity to tubercular antigen in children as 
compared to adults. 
     Kashyap et al take cutoff value of 11.39 U/L and has 
obtained sensitivity of 82% and specificity as 83% in TBM 
cases [15]. Rana et al take 10 U/L as cutoff value for diagno-
sis of TBM and found sensitivity 66.6% and specificity 90% 
[23]. Baheti et al found that CSF ADA may differentiate tu-
berculous from non-tuberculous meningitis even at a cut-off 
level of 6.5 U/L [24].
      In the present study, median ADA levels in CSF were sig-
nificantly high in TBM patients as compared to those with 
other etiologies. Ribera et al have also demonstrated similar 
finding but his study was in TBM patients of adult age group 
[25].
In conclusion, we found the sensitivity of the test to 
be  94.73%;  specificity  90.47%,  positive  predictive  value 
is 90.00 % and negative predictive value 95.00%, and so it 
can be concluded that ADA estimation in CSF is not only 
simple, inexpensive and rapid but also fairly specific method 
for making a diagnosis of tuberculous etiology in TBM, es-
pecially when there is a dilemma of differentiating the tu-
berculous  etiology  from  non-tuberculous.  For  this  reason 
CSF ADA estimation in TBM may find a place as a routine 
investigation.
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